Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Sanofi (SNY)

54.42   0.45 (0.83%) 03-31 16:00
Open: 54.43 Pre. Close: 53.97
High: 54.52 Low: 54.16
Volume: 2,019,692 Market Cap: 135,910(M)

Technical analysis

as of: 2023-03-31 4:22:12 PM
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 63.93     One year: 74.67
Support: Support1: 49.85    Support2: 46.83
Resistance: Resistance1: 54.74    Resistance2: 63.93
Pivot: 50.55
Moving Average: MA(5): 54.04     MA(20): 49.75
MA(100): 47.62     MA(250): 47.46
MACD: MACD(12,26): 1.7     Signal(9): 1
Stochastic oscillator: %K(14,3): 94     %D(3): 95.7
RSI: RSI(14): 78.5
52-week: High: 58.09  Low: 36.9
Average Vol(K): 3-Month: 2,011 (K)  10-Days: 2,199 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ SNY ] has closed below upper band by 16.3%. Bollinger Bands are 244.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 6 days. This is a sign that the current trend might continue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 54.58 - 54.8 54.8 - 54.99
Low: 53.55 - 53.82 53.82 - 54.06
Close: 53.96 - 54.39 54.39 - 54.77

Company Description

Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Headline News

Mon, 27 Mar 2023
Sanofi (SNY) Outpaces Stock Market Gains: What You Should Know - Nasdaq

Mon, 27 Mar 2023
Sanofi SA (SNY) Up 1.18% in Premarket Trading - InvestorsObserver

Sun, 26 Mar 2023
Ellsworth Advisors LLC Invests $441000 in Sanofi (NASDAQ:SNY) - MarketBeat

Thu, 23 Mar 2023
Sanofi's (SNY) Dupixent Meets Goal in Pivotal COPD Study - Nasdaq

Tue, 21 Mar 2023
Sanofi's (SNY) Dupixent Gets EU Nod for Eczema in Young Kids - Nasdaq

Tue, 21 Mar 2023
Sanofi (SNY) Gains But Lags Market: What You Should Know - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Drug Manufacturers—General
Shares Out. 2,510 (M)
Shares Float 2,220 (M)
% Held by Insiders 0 (%)
% Held by Institutions 10.3 (%)
Shares Short 2,960 (K)
Shares Short P.Month 2,840 (K)

Stock Financials

EPS 5.84
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 25.19
Profit Margin (%) 14.8
Operating Margin (%) 26.1
Return on Assets (ttm) 6
Return on Equity (ttm) 9.5
Qtrly Rev. Growth 10
Gross Profit (p.s.) 12.62
Sales Per Share 18.08
EBITDA (p.s.) 5.8
Qtrly Earnings Growth 29.2
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 9.31
PEG Ratio 0.8
Price to Book value 2.16
Price to Sales 3
Price to Cash Flow 0

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date 2021-05-25
Ex-Dividend Date 2021-05-02
Your Ad Here
StockChart iOS
StoxlineLite iOS
StoxlineLite iOS
OptionCalc iOS
StockChart Android
StoxlineLite Android
StoxlinePro Android
OptionCalc Android
(c) 2006-2022 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.